Stephen Joel Coons1, Sonya Eremenco2, J Jason Lundy3, Paul O'Donohoe4, Hannah O'Gorman5, William Malizia6. 1. Critical Path Institute, Tucson, AZ, USA. sjcoons@c-path.org. 2. Evidera, Bethesda, MD, USA. 3. Critical Path Institute, Tucson, AZ, USA. 4. CRF Health, London, UK. 5. Exco InTouch Limited, Nottingham, UK. 6. Sungard Availability Services, Wayne, PA, USA.
With regard to the following sentence in the ‘Disclosures’ section: “During the preparation of this manuscript, Ms. Eremenco, Mr. O’Donohoe, Ms. O’Gorman, and Mr. Malizia were employed by companies that provide ePRO systems and/or ePRO consulting services for sponsors of clinical trials.” It should have been specified that William Malizia was employed by Medidata Solutions during the preparation of the manuscript. His affiliation in the article is Sungard Availability Services because this was his employer at the time of publication.
Authors: David H Gustafson; Lori L DuBenske; Amy K Atwood; Ming-Yuan Chih; Roberta A Johnson; Fiona McTavish; Andrew Quanbeck; Roger L Brown; James F Cleary; Dhavan Shah Journal: J Med Internet Res Date: 2017-11-14 Impact factor: 5.428